A blocking peptide containing 24 amino acids near the center of human IER3.
Points forts
Source
Synthetic
(Accession #: P46695) The IER3 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-051515 |
|---|
| Réf. fabricant | 18271456 |
|---|
| Gene ID (Entrez) | 8870 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76802. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | DIF-2, DIF2GLY96, Differentiation-dependent gene 2 protein, expressed in pancreatic carcinoma, gly96, mouse, homolog of, IEX-1, IE x 1 death protein, IEX-1 L, Immediate early protein GLY96, immediate early response 3, Immediate early response 3 protein, immediately early gene X-1, PRG1PACAP-responsive gene 1 protein, Protein DIF-2, Protein PRG1, radiation-inducible immediate-early gene IEX-1 |
|---|
| Symbole de gène(s) | IER3 |
|---|
| Type de produit | IER3 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 24 amino acids near the center of human IEX-1 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
